Biden Supports Waiving IP Protections for COVID-19 Vaccines. What Does That Mean for Pharma?
As you may have read, the Biden administration announced last week that it will support a proposal to temporarily waive certain intellectual property (IP) protections for COVID-19 vaccines and therapies.